Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in…
By Morris J. Brown, C. Palmer, A. Castaigne, P. Leeuw, G. Mancia, T. Rosenthal, L. Ruilope. The Lancet, 2000
1,204 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/a1c548e1f43c4610dccd028f9e0ac6f652a7ccbc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Douglas G. Altman
- David Moher
- P. Gøtzsche
- S. Laurent
- K. F. Schulz
- P. Devereaux
- Victor M. Montori
- Sally Hopewell
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “(315,321,322,331) Recently, angiotensin receptor antagonists (335) and ACE inhibitors (322) have been shown to be associated with significantly less new diabetes than calcium antagonists.”